Home / Stocks / NOVELIX
Back to all stocks
BSE · NOVELIX

NOVELIX PHARMACEUTICALS LIMITED (NOVELIX) Share Price

Sector: Healthcare · ISIN: INE314I01036

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,494
of 5,047 stocks
🏆 New peak
▲ 1351W▲ 1641M
Peak #2,494 · 17 Nov 2026

A microcap name in Healthcare, NOVELIX PHARMACEUTICALS LIMITED carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and posts a modest return on equity. Ownership as of Jul 2026.

Market Cap
196.44 Cr
P/E Ratio
57.02
P/B Ratio
3.13
ROE
5.50%
ROCE
6.70%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue44.73 Cr36.91 Cr25.19 Cr48.40 Cr
Net Profit1.56 Cr1.18 Cr91.19 L1.00 Cr
EPS0.570.490.430.58
Operating Profit2.00 Cr1.23 Cr1.23 Cr1.28 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
54.29%
Public
45.71%

PUBLIC BREAKDOWN

Individuals
42.69%

As of 09 Jul 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs